Featured Research

from universities, journals, and other organizations

BMI may predict heart disease risk for type-2 diabetic patients

Date:
November 17, 2013
Source:
Intermountain Medical Center
Summary:
Researchers have discovered a simple way to further predict a diabetic patient’s risk for heart disease: by measuring their body mass index or BMI.

Researchers from the Intermountain Medical Center Heart Institute, in collaboration with researchers from Johns Hopkins University and the National Institutes of Health, have discovered a simple way to further predict a diabetic patient's risk for heart disease: by measuring their body mass index or BMI.

Related Articles


The Intermountain Medical Center Heart Institute study is part of a larger study called faCTor-64, which is a landmark, randomized trial designed to determine if using CT scans to screen for heart disease in diabetic patients who don't have heart disease symptoms can help save lives.

As Intermountain researchers measured coronary artery plaque buildup in study participants, they discovered that a major controllable predictor of heart disease was BMI. Simply put: the greater the patient's BMI, the greater their risk for heart disease.

Researchers will present this study at the 2013 American Heart Association Scientific Sessions in Dallas, on Nov. 17 at 10 am, ET.

"Our study shows there's a strong linear relationship between BMI and plaque volume and composition," said J. Brent Muhlestein, MD, lead researcher and co-director of cardiovascular research at the Intermountain Medical Center Heart Institute in Murray, Utah. "So even being a little overweight is associated with more plaque, while being obese is associated with a lot of plaque."

Researchers say the findings are significant because heart disease causes about 75% of deaths in patients who have diabetes, but not everyone has obvious risk factors, such as smoking, high glucose levels, high cholesterol levels, or high blood pressure.

Patients with obvious risk factors can be treated, but for the patients who don't have obvious risk factors, their first indictor of heart disease is often in the form of a heart attack or stroke -- or even death.

Current methods to measure plaque buildup are invasive and costly, and are not used to screen patients who don't display signs of heart disease. However, the coronary computed tomography angiography (CCTA) offers a new, and less invasive way to screen these patients for heart disease.

"It may be that in diabetic patients without any symptoms of heart disease, their BMI could be used to determine if they need a CT scan to screen for plaque buildup," said Muhlestein. "We could then develop a treatment plan for at-risk patients.

Findings from the study may also change the way diabetic patients are treated. Current diabetic management strategies include three options:

‧ Insulin-sensitizing medication to help the body's tissues become more sensitive to insulin and decrease glucose production

‧ Insulin-stimulating therapy to increase the pancreas' production of insulin

‧ Insulin injections

When patients are treated with insulin therapy and injections, they commonly experience weight gain. "When you provide more insulin, it's associated in almost every study with increased weight gain," said Dr. Muhlestein.

While weight gain does not necessarily predict heart disease in non-diabetics, the findings of this study shows that weight gain in diabetics can indicate the buildup of plaque. This is significant because the degree of weight gain can be reduced by using other types of diabetic treatments, such as insulin sensitizing medication.

"Based on the findings of this study, choosing insulin sensitizing therapy, as the primary management strategy in diabetic patients may be beneficial by reducing the tendency towards elevated BMI's, said Dr. Muhlestein.

Not only will the results of this study help researchers better understand which treatments will reduce weight gain, but they will also help researchers predict who will get heart disease -- which will help physicians offer better long-term diabetic treatments to their patients.

"Our goal at the Intermountain Medical Center Heart Institute, is to learn how to predict who will get heart disease, so we can provide the best care possible and improve long-term outcomes -- rather than waiting until a person has a heart attack or even dies," he said.


Story Source:

The above story is based on materials provided by Intermountain Medical Center. The original article was written by Jess Gomez. Note: Materials may be edited for content and length.


Cite This Page:

Intermountain Medical Center. "BMI may predict heart disease risk for type-2 diabetic patients." ScienceDaily. ScienceDaily, 17 November 2013. <www.sciencedaily.com/releases/2013/11/131117155410.htm>.
Intermountain Medical Center. (2013, November 17). BMI may predict heart disease risk for type-2 diabetic patients. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/11/131117155410.htm
Intermountain Medical Center. "BMI may predict heart disease risk for type-2 diabetic patients." ScienceDaily. www.sciencedaily.com/releases/2013/11/131117155410.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins